IMPORTANCE: Combat places soldiers at risk for posttraumatic stress disorder (PTSD). The excessive rates of PTSD and other adjustment disorders in soldiers returning home make it imperative to identify risk and resilience factors that could be targeted by novel therapeutic treatments. OBJECTIVE: To investigate the interplay among attention to threat, combat exposure, and other risk factors for PTSD symptoms in soldiers deployed to combat. DESIGN AND SETTING: Longitudinal prospective study of Israeli Defense Force infantry soldiers carried out in 2008 through 2010. Repeated measurements during a 1-year period included baseline and predeployment data collected in training camps and deployment data collected in the combat theater. PARTICIPANTS: Infantry soldiers (1085 men; mean age, 18.8 years). MAIN OUTCOME MEASURES: Postcombat PTSD symptoms. RESULTS Soldiers developed threat vigilance during combat deployment, particularly when they were exposed to high-intensity combat, as indicated by faster response times to targets appearing at the location of threat relative to neutral stimuli (P < .001). Threat-related attention bias also interacted with combat exposure to predict risk for PTSD (P < .05). Bias toward threat at recruitment (P < .001) and bias away from threat just before deployment (P < .05) predicted postcombat PTSD symptoms. Moreover, these threat-related attention associations with PTSD were moderated by genetic and environmental factors, including serotonin transporter (5-HTTLPR) genotype. CONCLUSIONS AND RELEVANCE: Combat exposure interacts with threat-related attention to place soldiers at risk for PTSD, and interactions with other risk factors account for considerable variance in PTSD vulnerability. Understanding these associations informs research on novel attention bias modification techniques and prevention of PTSD.
IMPORTANCE: Combat places soldiers at risk for posttraumatic stress disorder (PTSD). The excessive rates of PTSD and other adjustment disorders in soldiers returning home make it imperative to identify risk and resilience factors that could be targeted by novel therapeutic treatments. OBJECTIVE: To investigate the interplay among attention to threat, combat exposure, and other risk factors for PTSD symptoms in soldiers deployed to combat. DESIGN AND SETTING: Longitudinal prospective study of Israeli Defense Force infantry soldiers carried out in 2008 through 2010. Repeated measurements during a 1-year period included baseline and predeployment data collected in training camps and deployment data collected in the combat theater. PARTICIPANTS: Infantry soldiers (1085 men; mean age, 18.8 years). MAIN OUTCOME MEASURES: Postcombat PTSD symptoms. RESULTS Soldiers developed threat vigilance during combat deployment, particularly when they were exposed to high-intensity combat, as indicated by faster response times to targets appearing at the location of threat relative to neutral stimuli (P < .001). Threat-related attention bias also interacted with combat exposure to predict risk for PTSD (P < .05). Bias toward threat at recruitment (P < .001) and bias away from threat just before deployment (P < .05) predicted postcombat PTSD symptoms. Moreover, these threat-related attention associations with PTSD were moderated by genetic and environmental factors, including serotonin transporter (5-HTTLPR) genotype. CONCLUSIONS AND RELEVANCE: Combat exposure interacts with threat-related attention to place soldiers at risk for PTSD, and interactions with other risk factors account for considerable variance in PTSD vulnerability. Understanding these associations informs research on novel attention bias modification techniques and prevention of PTSD.
Authors: Charles W Hoge; Carl A Castro; Stephen C Messer; Dennis McGurk; Dave I Cotting; Robert L Koffman Journal: N Engl J Med Date: 2004-07-01 Impact factor: 91.245
Authors: K P Lesch; D Bengel; A Heils; S Z Sabol; B D Greenberg; S Petri; J Benjamin; C R Müller; D H Hamer; D L Murphy Journal: Science Date: 1996-11-29 Impact factor: 47.728
Authors: Sebastian Trautmann; Jan Richter; Markus Muehlhan; Michael Höfler; Hans-Ulrich Wittchen; Katharina Domschke; Andreas Ströhle; Alfons O Hamm; Heike Weber; Tilo Kircher; Volker Arolt; Alexander L Gerlach; Georg W Alpers; Thomas Fydrich; Thomas Lang; Andreas Reif Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-07-15 Impact factor: 5.270
Authors: Lies Notebaert; Jessie Veronica Georgiades; Matthew Herbert; Ben Grafton; Sam Parsons; Elaine Fox; Colin MacLeod Journal: Psychol Res Date: 2018-08-21
Authors: Michael T Nedelcovych; Robert W Gould; Xiaoyan Zhan; Michael Bubser; Xuewen Gong; Michael Grannan; Analisa T Thompson; Magnus Ivarsson; Craig W Lindsley; P Jeffrey Conn; Carrie K Jones Journal: ACS Chem Neurosci Date: 2015-01-28 Impact factor: 4.418
Authors: Brian M Iacoviello; Gang Wu; Rany Abend; James W Murrough; Adriana Feder; Eyal Fruchter; Yoav Levinstein; Ilan Wald; Christopher R Bailey; Daniel S Pine; Alexander Neumeister; Yair Bar-Haim; Dennis S Charney Journal: J Trauma Stress Date: 2014-03-06
Authors: Hilary A Marusak; Allesandra S Iadipaolo; Shelley Paulisin; Felicity W Harper; Jeffrey W Taub; Kristopher Dulay; Farrah Elrahal; Craig Peters; Kelsey Sala-Hamrick; Laura M Crespo; Christine A Rabinak Journal: Pediatr Blood Cancer Date: 2018-09-30 Impact factor: 3.167
Authors: Jennifer C Britton; Yair Bar-Haim; Michelle A Clementi; Lindsey S Sankin; Gang Chen; Tomer Shechner; Maxine A Norcross; Carolyn N Spiro; Kara M Lindstrom; Daniel S Pine Journal: Dev Cogn Neurosci Date: 2012-11-10 Impact factor: 6.464